Evidence map›Paper›PMID 33142354›Full record

Observational studyClinical and translational science2021

Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease.

Voytek Slowik, Heather Wasserkrug, Ryan T Fischer, Mark Connelly, Amanda D Deacy, Sarah Hampl, James F Daniel

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Voytek SlowikDivision of Pediatric Gastroenterology, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
Heather WasserkrugDivision of Pediatric Gastroenterology, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
Ryan T FischerDivision of Pediatric Gastroenterology, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
Mark ConnellyDivision of Developmental and Behavioral Health, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
Amanda D DeacyDivision of Pediatric Gastroenterology, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
Sarah HamplDivision of General Academic Pediatrics and Center for Children's Healthy Lifestyles & Nutrition, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
James F DanielDivision of Pediatric Gastroenterology, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA.
University of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in pediatrics with limited treatment options. We prospectively assessed outcomes in patients managed in a hepatology clinic (HC) alone vs. those managed in combination with a multidisciplinary weight management program (MWMP). We describe each group's readiness to change at the time of NAFLD diagnosis. Patients diagnosed with NAFLD were given a modified Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) at enrollment (T1) to assess readiness to change. They were then followed at 3-9 months (T2) and at 10-15 months (T3). Linear mixed models were used to evaluate changes in body mass index (BMI), BMI z-score, and transaminases over time and between the two groups. There were no significant treatment group main effects or treatment × time interactions for our primary end points for HC alone (n = 75) or with MWMP (n = 18). There was a significant main effect for time for BMI z-score, with BMI z-scores declining on average by 0.0568 (P = 0.004) from visit to visit. Low SOCRATES subscales scores in HC alone (n = 33) or with MWMP (n = 4) suggested a patient population with low recognition of disease and likelihood of taking steps for change. Patients with obesity and NAFLD had low scores on all three SOCRATES subscales. Despite this, both groups had improvement in BMI z-score without significant difference between the two treatment groups in other primary end points. Further study is needed to identify the most effective patient selection and treatment strategies for pediatric patients with NAFLD, including pharmacotherapy and surgery.

Indexed as

Weight Reduction ProgramsAdolescentBody Mass IndexChildChild, PreschoolFemaleFollow-Up StudiesHumansMaleNon-alcoholic Fatty Liver DiseasePatient ParticipationPediatric ObesityProspective StudiesTreatment Outcome

Identifiers

PMID33142354
PMCPMC7993262
OpenAlexW3095450269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.